PodcastCancer

Science Signaling Podcast: 29 March 2011

Sci. Signal.  29 Mar 2011:
Vol. 4, Issue 166, pp. pc6
DOI: 10.1126/scisignal.2001941

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

This Podcast features a conversation with the senior author of a Research Article published in the March 29 issue of Science Signaling. Thomas Graeber discusses his group’s phosphoproteomic analysis of a leukemia cell line, which reveals a mechanism by which leukemia cells may become resistant to chemotherapeutic agents that target tyrosine kinases. They found that the sensitivity of leukemias driven by the Bcr-Abl fusion protein to tyrosine kinase inhibitors depends on the cells’ reliance on negative feedback mechanisms that limit the activity of the Src family of tyrosine kinases.

View Full Text

Related Content